These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8785035)

  • 1. Effect of peritoneal dialysis on cytokine production by peritoneal cells.
    Topley N; Williams JD
    Blood Purif; 1996; 14(2):188-97. PubMed ID: 8785035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability.
    Zemel D; Krediet RT
    Blood Purif; 1996; 14(2):198-216. PubMed ID: 8785036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of apoptosis by lethal cytokines in human mesothelial cells.
    Catalan MP; Subirá D; Reyero A; Selgas R; Ortiz-Gonzalez A; Egido J; Ortiz A
    Kidney Int; 2003 Jul; 64(1):321-30. PubMed ID: 12787425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis.
    Fieren MW
    Blood Purif; 1996; 14(2):179-87. PubMed ID: 8785034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and mesothelial cells in bacterial peritonitis.
    Topley N; Mackenzie RK; Williams JD
    Immunobiology; 1996 Oct; 195(4-5):563-73. PubMed ID: 8933157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal function and peritonitis in patients on peritoneal dialysis.
    Friedlander M
    J Lab Clin Med; 1993 Dec; 122(6):639-40. PubMed ID: 8245682
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing.
    Yung S; Davies M
    Kidney Int; 1998 Dec; 54(6):2160-9. PubMed ID: 9853283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritonitis: pathophysiology and local defense mechanisms.
    Heemken R; Gandawidjaja L; Hau T
    Hepatogastroenterology; 1997; 44(16):927-36. PubMed ID: 9261580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of repeated peritonitis on peritoneal membrane function in children on chronic peritoneal dialysis.
    Wang HH; Lin CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 May; 65(5):205-11. PubMed ID: 12166764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.
    Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT
    Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
    Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peritoneal membrane in chronic peritoneal dialysis.
    Krediet RT
    Kidney Int; 1999 Jan; 55(1):341-56. PubMed ID: 9893150
    [No Abstract]   [Full Text] [Related]  

  • 20. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.